Spinal cord multi‐parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis

Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic r...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 24; no. 8; pp. 1040 - 1046
Main Authors Querin, G., El Mendili, M. M., Lenglet, T., Delphine, S., Marchand‐Pauvert, V., Benali, H., Pradat, P.‐F.
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.08.2017
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty‐nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross‐sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3–C4 and C5–C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
AbstractList Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis ( ALS ). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord ( SC ) atrophy described by magnetic resonance imaging ( MRI ) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty‐nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross‐sectional area ( CSA ) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3–C4 and C5–C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
BACKGROUND AND PURPOSEAssessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival.METHODSForty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.RESULTSOn building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1.CONCLUSIONSIt is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty‐nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross‐sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3–C4 and C5–C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
Background: Assessing survival is a critical issue in patients with Amyotrophic Lateral Sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by MRI and disease progression.Aim of the study was than to determine the predictive added value of multimodal SC MRI on survival.Methods: 49 ALS patients were recruited and clinical data collected. Patients were scored on ALSFRS-R and manual muscle testing. They were followed longitudinally to assess survival. Cervical spinal cord was imaged using 3T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. DTI metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.Results: When building a multivariate Cox regression model with clinical and MRI parameters, FA, MTR, and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, hazard ratio (HR) calculated for CSA at C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had HR very close to 1.Conclusions: We suggest that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, results confirmation in independent bigger cohorts of patients is warranted.
Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Forty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted.
Author Querin, G.
Pradat, P.‐F.
Delphine, S.
El Mendili, M. M.
Lenglet, T.
Marchand‐Pauvert, V.
Benali, H.
Author_xml – sequence: 1
  givenname: G.
  orcidid: 0000-0001-6938-6368
  surname: Querin
  fullname: Querin, G.
  organization: UPMC Univ Paris 06
– sequence: 2
  givenname: M. M.
  surname: El Mendili
  fullname: El Mendili, M. M.
  organization: Icahn School of Medicine
– sequence: 3
  givenname: T.
  surname: Lenglet
  fullname: Lenglet, T.
  organization: Hôpital Pitié‐Salpêtrière
– sequence: 4
  givenname: S.
  surname: Delphine
  fullname: Delphine, S.
  organization: Institut Du Cerveau Et De La Moelle Épinière ‐ IHU‐A‐ICM
– sequence: 5
  givenname: V.
  surname: Marchand‐Pauvert
  fullname: Marchand‐Pauvert, V.
  organization: UPMC Univ Paris 06
– sequence: 6
  givenname: H.
  surname: Benali
  fullname: Benali, H.
  organization: UPMC Univ Paris 06
– sequence: 7
  givenname: P.‐F.
  surname: Pradat
  fullname: Pradat, P.‐F.
  email: pierre-francois.pradat@aphp.fr
  organization: Hôpital Pitié‐Salpêtrière Paris
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28586096$$D View this record in MEDLINE/PubMed
https://hal.sorbonne-universite.fr/hal-01540346$$DView record in HAL
BookMark eNp1kc1u1DAQxy1URD_gwAugSFzgkNbjryTHqloo0goOwNnyOpPWlWMHO9lqbzwCz8iT4GVLkZDwZcaj3_w94_8pOQoxICEvgZ5DORcY8Bw4Z90TcgJCtXW5wFHJuYRaAoVjcprzHaWUNYw-I8esla2inToh6fPkgvGVjamvxsXP7uf3H5NJZsQ5OVuN5ibgXJKEOQYTLFau1Fy4qYaYqrykrduW_ilh7-zsYqhcqMy4i3OK021p9GbGVIhsPaaYXX5Ong7GZ3zxEM_I13erL1fX9frT-w9Xl-vairbt6gFFj3xgQkoBSFsmO2aHxlAlwWBnhTJWqV5RpaRlmw1yFBxww1s0zQANPyNvD7q3xusplbHTTkfj9PXlWu9rFKSgXKgtFPbNgZ1S_LZgnvXoskXvTcC4ZA0dVUIp4Kygr_9B7-KSyh_uKWhbykSj_j5uy8454fA4AVC9N00X0_Rv0wr76kFx2YzYP5J_XCrAxQG4dx53_1fSq4-rg-QvmsikCQ
CitedBy_id crossref_primary_10_1080_14737175_2020_1715798
crossref_primary_10_1136_jnnp_2017_317214
crossref_primary_10_1111_risa_14128
crossref_primary_10_1111_ene_16268
crossref_primary_10_1016_j_nicl_2019_101984
crossref_primary_10_1038_s41598_023_47935_7
crossref_primary_10_1038_s41598_020_70125_8
crossref_primary_10_1002_mp_15936
crossref_primary_10_3389_fneur_2018_00844
crossref_primary_10_1016_j_nicl_2018_101618
crossref_primary_10_1002_nbm_3801
crossref_primary_10_1002_ana_25706
crossref_primary_10_1080_21678421_2017_1407795
crossref_primary_10_1016_S1474_4422_21_00465_8
crossref_primary_10_1097_WCO_0000000000000569
crossref_primary_10_3389_fneur_2019_00350
crossref_primary_10_1002_ana_25520
crossref_primary_10_1016_j_nmd_2019_07_008
crossref_primary_10_1002_acn3_51712
crossref_primary_10_17826_cumj_1228302
crossref_primary_10_1007_s00234_023_03191_0
crossref_primary_10_1016_j_cnp_2023_12_003
crossref_primary_10_1111_ene_13846
crossref_primary_10_1080_14737175_2018_1463160
crossref_primary_10_1292_jvms_21_0370
crossref_primary_10_1186_s40035_021_00255_0
crossref_primary_10_1016_j_nicl_2022_103199
crossref_primary_10_3389_fneur_2019_00229
crossref_primary_10_1038_s41598_018_19938_2
crossref_primary_10_1038_s41596_021_00588_0
crossref_primary_10_1007_s00415_020_10181_2
crossref_primary_10_1007_s00415_023_11727_w
crossref_primary_10_1093_braincomms_fcab143
crossref_primary_10_3389_fneur_2018_01065
crossref_primary_10_1053_j_sult_2023_03_016
crossref_primary_10_1097_WCO_0000000000001169
crossref_primary_10_1016_j_jacr_2020_01_042
crossref_primary_10_1016_j_neures_2017_11_005
Cites_doi 10.3109/21678421.2014.903974
10.1136/jnnp-2015-310998
10.3109/21678421.2013.852589
10.3109/17482960802566824
10.1002/mus.23720
10.1136/jnnp.2008.154252
10.1038/nrn3430
10.1016/S0022-510X(99)00210-5
10.1007/s007020050088
10.1002/jmri.24571
10.3109/17482968.2012.701308
10.1371/journal.pone.0095516
10.1371/journal.pone.0152439
10.1016/j.nicl.2016.10.008
10.1016/j.neuroimage.2010.11.089
10.1038/nrneurol.2014.184
10.1186/s12883-016-0672-6
10.1038/nrneurol.2013.153
10.1212/01.WNL.0000095961.66830.03
10.1136/jnnp.2006.100032
10.1016/j.neuroimage.2010.06.060
10.1159/000341316
10.3109/21678421.2013.844168
10.1080/14737159.2016.1199277
10.1007/s13311-016-0484-9
10.1001/archneurpsyc.1953.02320260029002
ContentType Journal Article
Copyright 2017 EAN
2017 EAN.
2017 European Federation of Neurological Societies
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2017 EAN
– notice: 2017 EAN.
– notice: 2017 European Federation of Neurological Societies
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7U7
C1K
K9.
7X8
1XC
VOOES
DOI 10.1111/ene.13329
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic


ProQuest Health & Medical Complete (Alumni)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-1331
EndPage 1046
ExternalDocumentID oai_HAL_hal_01540346v1
10_1111_ene_13329
28586096
ENE13329
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Investissements d'Avenir
  funderid: ANR‐10‐IAIHU‐06
– fundername: Institut pour la Recherche sur la Moelle épinière et l'Encéphale (IRME)
– fundername: Association Française contre les Myopathies‐Téléthon (AFM‐Téléthon)
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
169
1OB
1OC
24P
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADPDF
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFRAH
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F5P
FEDTE
FUBAC
FYBCS
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIG
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
TEORI
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7U7
C1K
K9.
7X8
1XC
VOOES
ID FETCH-LOGICAL-c4889-fe4de3f245541e082592cf7a0651ae9c46ac66d60665c2bbe3e431eb38ea7f173
IEDL.DBID DR2
ISSN 1351-5101
IngestDate Fri Sep 06 12:36:29 EDT 2024
Fri Aug 16 09:44:15 EDT 2024
Sat Aug 31 00:00:05 EDT 2024
Fri Aug 23 03:00:03 EDT 2024
Sat Sep 28 08:49:00 EDT 2024
Sat Aug 24 01:18:05 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords spinal cord MRI
spinal cord atrophy
survival prediction
motor neuron degeneration
amyotrophic lateral sclerosis
biomarkers
Language English
License 2017 EAN.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4889-fe4de3f245541e082592cf7a0651ae9c46ac66d60665c2bbe3e431eb38ea7f173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6938-6368
OpenAccessLink https://hal.sorbonne-universite.fr/hal-01540346
PMID 28586096
PQID 1918802476
PQPubID 1066358
PageCount 7
ParticipantIDs hal_primary_oai_HAL_hal_01540346v1
proquest_miscellaneous_1906466132
proquest_journals_1918802476
crossref_primary_10_1111_ene_13329
pubmed_primary_28586096
wiley_primary_10_1111_ene_13329_ENE13329
PublicationCentury 2000
PublicationDate August 2017
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: August 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle European journal of neurology
PublicationTitleAlternate Eur J Neurol
PublicationYear 2017
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References 2010; 53
2014; 5
2013; 14
2013; 47
2009; 10
1994; 169
2009; 80
2017; 14
2013; 12
2015; 41
2016; 87
2014; 15
2011; 55
1998; 105
2003; 61
1953; 69
2016; 16
2007; 78
2014; 22
2016; 13
2014; 10
2013; 9
2016; 11
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
Cedarbaum JM (e_1_2_7_17_1) 1994; 169
e_1_2_7_25_1
e_1_2_7_24_1
e_1_2_7_23_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – volume: 9
  start-page: 513
  year: 2013
  end-page: 524
  article-title: 25 years of neuroimaging in amyotrophic lateral sclerosis
  publication-title: Nat Rev Neurol
– volume: 14
  start-page: 11
  year: 2017
  end-page: 23
  article-title: Neuroimaging endpoints in amyotrophic lateral sclerosis
  publication-title: Neurotherapeutics
– volume: 69
  start-page: 171
  year: 1953
  end-page: 92
  article-title: Amyotrophic lateral sclerosis. A clinicoanatomic study of 53 cases
  publication-title: Arch Neurol Psychiatr
– volume: 105
  start-page: 689
  year: 1998
  end-page: 701
  article-title: Evaluation of neuronal loss, astrocytosis and abnormalities of cytoskeletal components of large motor neurons in the human anterior horn in aging
  publication-title: J Neural Transm
– volume: 53
  start-page: 576
  year: 2010
  end-page: 583
  article-title: Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis
  publication-title: NeuroImage
– volume: 22
  start-page: e95516
  year: 2014
  article-title: Multi‐parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis
  publication-title: PLoS One
– volume: 10
  start-page: 661
  year: 2014
  end-page: 670
  article-title: The phenotypic variability of amyotrophic lateral sclerosis
  publication-title: Nat Rev Neurol
– volume: 10
  start-page: 310
  year: 2009
  end-page: 232
  article-title: Prognostic factors in ALS: a critical review
  publication-title: Amyotroph Lateral Scler
– volume: 13
  start-page: 361
  year: 2016
  end-page: 369
  article-title: Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis
  publication-title: Neuroimage Clin
– volume: 14
  start-page: 30
  year: 2013
  end-page: 38
  article-title: Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– volume: 47
  start-page: 760
  year: 2013
  end-page: 2
  article-title: 7‐T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis
  publication-title: Muscle Nerve
– volume: 22
  start-page: e95516
  year: 2014
  article-title: Fast and accurate semi‐automated segmentation method of spinal cord MR images at 3T applied to the construction of a cervical spinal cord template
  publication-title: PLoS One
– volume: 16
  start-page: 155
  year: 2016
  article-title: The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review
  publication-title: BMC Neurol
– volume: 5
  start-page: 93
  year: 2014
  end-page: 97
  article-title: Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– volume: 11
  start-page: e0152439
  year: 2016
  article-title: Cervical spinal cord atrophy profile in adult SMN1‐linked SMA
  publication-title: PLoS One
– volume: 169
  start-page: 13
  year: 1994
  end-page: 21
  article-title: The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)
  publication-title: J Neurol Sci
– volume: 78
  start-page: 480
  year: 2007
  end-page: 484
  article-title: Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 15
  start-page: 84
  year: 2014
  end-page: 92
  article-title: Multimodal tract‐based analysis in ALS patients at 7T: a specific white matter profile?
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– volume: 14
  start-page: 248
  year: 2013
  end-page: 264
  article-title: The changing scene of amyotrophic lateral sclerosis
  publication-title: Nat Rev Neurosci
– volume: 87
  start-page: 628
  year: 2016
  end-page: 632
  article-title: Rate of disease progression: a prognostic biomarker in ALS
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 80
  start-page: 53
  year: 2009
  end-page: 55
  article-title: A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 61
  start-page: 1503
  year: 2003
  end-page: 1507
  article-title: A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis
  publication-title: Neurology
– volume: 16
  start-page: 853
  year: 2016
  end-page: 68
  article-title: Further development of biomarkers in amyotrophic lateral sclerosis
  publication-title: Expert Rev Mol Diagn
– volume: 41
  start-page: 454
  year: 2015
  end-page: 9
  article-title: Validation of a semiautomated spinal cord segmentation method
  publication-title: J Magn Reson Imaging
– volume: 55
  start-page: 1024
  year: 2011
  end-page: 1033
  article-title: Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI
  publication-title: NeuroImage
– volume: 12
  start-page: 81
  year: 2013
  end-page: 90
  article-title: Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15‐year experience
  publication-title: Neurodegener Dis
– volume: 15
  start-page: 453
  year: 2014
  end-page: 456
  article-title: Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis
  publication-title: Amyotroph Lateral Scler Frontotemporal Degener
– ident: e_1_2_7_4_1
  doi: 10.3109/21678421.2014.903974
– ident: e_1_2_7_5_1
  doi: 10.1136/jnnp-2015-310998
– ident: e_1_2_7_15_1
  doi: 10.3109/21678421.2013.852589
– ident: e_1_2_7_7_1
  doi: 10.3109/17482960802566824
– ident: e_1_2_7_12_1
  doi: 10.1002/mus.23720
– ident: e_1_2_7_9_1
  doi: 10.1136/jnnp.2008.154252
– ident: e_1_2_7_2_1
  doi: 10.1038/nrn3430
– volume: 169
  start-page: 13
  year: 1994
  ident: e_1_2_7_17_1
  article-title: The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)
  publication-title: J Neurol Sci
  doi: 10.1016/S0022-510X(99)00210-5
  contributor:
    fullname: Cedarbaum JM
– ident: e_1_2_7_23_1
  doi: 10.1007/s007020050088
– ident: e_1_2_7_19_1
  doi: 10.1002/jmri.24571
– ident: e_1_2_7_11_1
  doi: 10.3109/17482968.2012.701308
– ident: e_1_2_7_10_1
  doi: 10.1371/journal.pone.0095516
– ident: e_1_2_7_20_1
  doi: 10.1371/journal.pone.0152439
– ident: e_1_2_7_27_1
  doi: 10.1016/j.nicl.2016.10.008
– ident: e_1_2_7_21_1
  doi: 10.1016/j.neuroimage.2010.11.089
– ident: e_1_2_7_3_1
  doi: 10.1038/nrneurol.2014.184
– ident: e_1_2_7_28_1
  doi: 10.1186/s12883-016-0672-6
– ident: e_1_2_7_8_1
  doi: 10.1038/nrneurol.2013.153
– ident: e_1_2_7_16_1
  doi: 10.1371/journal.pone.0095516
– ident: e_1_2_7_18_1
  doi: 10.1212/01.WNL.0000095961.66830.03
– ident: e_1_2_7_14_1
  doi: 10.1136/jnnp.2006.100032
– ident: e_1_2_7_13_1
  doi: 10.1016/j.neuroimage.2010.06.060
– ident: e_1_2_7_6_1
  doi: 10.1159/000341316
– ident: e_1_2_7_24_1
  doi: 10.3109/21678421.2013.844168
– ident: e_1_2_7_25_1
  doi: 10.1080/14737159.2016.1199277
– ident: e_1_2_7_26_1
  doi: 10.1007/s13311-016-0484-9
– ident: e_1_2_7_22_1
  doi: 10.1001/archneurpsyc.1953.02320260029002
SSID ssj0002720
Score 2.4305656
Snippet Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the...
Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease...
Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis ( ALS ). Neuroimaging seems to be promising in the...
Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the...
BACKGROUND AND PURPOSEAssessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the...
Background: Assessing survival is a critical issue in patients with Amyotrophic Lateral Sclerosis (ALS). Neuroimaging seems to be promising in the assessment...
SourceID hal
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1040
SubjectTerms Adult
Aged
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - diagnostic imaging
Amyotrophic Lateral Sclerosis - mortality
Amyotrophic Lateral Sclerosis - pathology
Anisotropy
Atrophy
Bioengineering
Biomarkers
Cross-Sectional Studies
Diffusion Tensor Imaging - methods
Disease Progression
Female
Humans
Imaging
Life Sciences
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Mathematical models
Medical imaging
Middle Aged
motor neuron degeneration
Multimodal Imaging
Neuroimaging
Neurology
Neurons and Cognition
NMR
Nuclear magnetic resonance
Patients
Predictions
Prognosis
Resonance
Spinal cord
Spinal Cord - diagnostic imaging
Spinal Cord - pathology
spinal cord atrophy
spinal cord MRI
Survival
survival prediction
Survival Rate
Vertebrae
Title Spinal cord multi‐parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.13329
https://www.ncbi.nlm.nih.gov/pubmed/28586096
https://www.proquest.com/docview/1918802476/abstract/
https://search.proquest.com/docview/1906466132
https://hal.sorbonne-universite.fr/hal-01540346
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RDqgXXn0QXnJRD1yyIo6TbNQTQotWCDiUInFAimyvXVawyWqziwQnfgK_kV_SGedRKEJCPUTKw3nZM5Pvi8efAb5rqzQJTPoYHLkvEqX8lNNmwK21A25S5RJkT-P-uTi6iC7m4EczFqbSh2h_uJFnuHhNDi5V-czJMRR0kGBxGrxHQnoEiH7-lY6i_kVHtqLAJ7urVYUoi6c988W36MMVZUK-hpkvUav77BwuwWXzwFW2yXVnNlUdff-PluN_vtEyLNZwlO1X9rMCcyZfhYWTusP9E0zOxjRtFiOOylzy4dPDI8mFj2gmLs1G8ndOwyAZsvaCtDsMG47cxEcM0TArZxiJ0JbZeEKXJCNgw5zJ0V0xnRTjKzzxRtIY6BtW4v2xloblZzg_7P066Pv1NA2-FpQjZY0YmNBygcgkMEQ5U65tIhHcBNKkWsRSx_GAmFKkuVImNIhakMR3jUxskIRfYD4vcrMGzCqThLHQaWRSsSe7SqskMkj-cRmEqfJgp2mwbFypcWQNi8Hay1ztYSFsyvY46Wf3948z2keAcS8U8W3gwWbT0lnttWWG3BXDGRdJ7MG39jD6G3WiyNwUMyqDIA5BTcg9-FpZSHsr3o26MXJCD3ZdO7_9jFnvtOdW1t9fdAM-csIULvtwE-ank5nZQkQ0VdvO9P8AwMAItg
link.rule.ids 230,315,786,790,891,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkCiXFmihaSkYxKGXrIjjJBupF1QtWmDZAw-JSxXZXrusyiarfVRqT_0J_Y38EmacR6FVpaqHSHk4L3tm8n3x-DPAgbZKk8Ckj8GR-yJRyk85bQbcWjvgJlUuQbYfd6_F6U10swAf6rEwpT5E88ONPMPFa3Jw-iH9yMsxFrSQYfF0EZbR3SNHqC5-iUdRD6OjW1Hgk-VVukKUx9Oc-uRrtHhLuZB_As2nuNV9eI5fwKf6kct8ky-t-Uy19Pff1Bz_953W4HmFSNlRaULrsGDyDVg5r_rcX8LkckwzZzGiqczlH97_-EmK4SOajEuzkfyc00hIhsS9IPkOw4YjN_cRQ0DMpnMMRmjObDyhS5IdsGHO5OhbMZsU41s88U7SMOg7NsX7YzUNp6_g-rhz9bHrVzM1-FpQmpQ1YmBCywWCk8AQ60y5tolEfBNIk2oRSx3HAyJLkeZKmdAgcEEe3zYysUESbsJSXuTmNTCrTBLGQqeRScWhbCutksgg_8dlEKbKg_26xbJxKciR1UQGay9ztYeFsC2b4ySh3T3qZbSPMONhKOKvgQfbdVNnleNOM6SvGNG4SGIP9prD6HLUjyJzU8ypDOI4xDUh92CrNJHmVrwdtWOkhR68dw3992fMOv2OW3nz70V34Vn36ryX9U76Z29hlRPEcMmI27A0m8zNOwRIM7Xj_OABScYM2A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Raq4lHcJFDCIA5esGsdxNuJUwa4WKCsEVOoBKbIdm67aTaJ9VConfgK_kV_CjPOAgpAQhyjZxNkk9szk--LxZ4CnxmlDApMhBkceilTrMOP0M-LOuYLbTPsE2amcHInXx8nxBjzvxsI0-hD9BzfyDB-vycHrwv3i5BgKBkiweLYJV4TENSGi9z-1o6iD0bOtJArJ8FpZIUrj6U-99DLaPKFUyD9x5mXY6t8742vwqbvjJt3kdLBe6YH58puY438-0nXYafEoO2gM6AZs2PImbL9te9xvweJDTfNmMSKpzGcffv_6jfTC5zQVl2Fz9bmkcZAMaXtF4h2WzeZ-5iOGcJgt1xiK0JhZvaC_JCtgs5Kp-UW1WlT1CZ54pmgQ9Blb4vWxlmbL23A0Hn18MQnbeRpCIyhJyllR2NhxgdAkssQ5M25cqhDdRMpmRkhlpCyIKiWGa21ji7AFWfzQqtRFaXwHtsqqtHeBOW3TWAqTJTYT-2qojU4Ti-wflyLOdABPugbL60aOI-9oDNZe7msPC2FT9sdJQHtycJjTPkKM-7GQ51EAe11L563bLnMkrxjPuEhlAI_7w-hw1IuiSlutqQyiOEQ1MQ9gt7GQ_lJ8mAwlksIAnvl2_vs95qPpyG_c-_eij2D73ctxfvhq-uY-XOWEL3wm4h5srRZr-wDR0Uo_9F7wAyUMC4c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spinal+cord+multi%E2%80%90parametric+magnetic+resonance+imaging+for+survival+prediction+in+amyotrophic+lateral+sclerosis&rft.jtitle=European+journal+of+neurology&rft.au=Querin%2C+G.&rft.au=El+Mendili%2C+M.+M.&rft.au=Lenglet%2C+T.&rft.au=Delphine%2C+S.&rft.date=2017-08-01&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=24&rft.issue=8&rft.spage=1040&rft.epage=1046&rft_id=info:doi/10.1111%2Fene.13329&rft.externalDBID=10.1111%252Fene.13329&rft.externalDocID=ENE13329
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon